BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND DNMT3A, Q9Y6K1, 1788, ENSG00000119772, DNMT3A2, M_HsaIIIA AND Prognosis
17 results:

  • 1. dCas9/CRISPR-based methylation of O-6-methylguanine-DNA methyltransferase enhances chemosensitivity to temozolomide in malignant glioma.
    Zapanta Rinonos S; Li T; Pianka ST; Prins TJ; Eldred BSC; Kevan BM; Liau LM; Nghiemphu PL; Cloughesy TF; Lai A
    J Neurooncol; 2024 Jan; 166(1):129-142. PubMed ID: 38224404
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Genomic characterization of IDH-mutant astrocytoma progression to grade 4 in the treatment setting.
    Rautajoki KJ; Jaatinen S; Hartewig A; Tiihonen AM; Annala M; Salonen I; Valkonen M; Simola V; Vuorinen EM; Kivinen A; Rauhala MJ; Nurminen R; Maass KK; Lahtela SL; Jukkola A; Yli-Harja O; Helén P; Pajtler KW; Ruusuvuori P; Haapasalo J; Zhang W; Haapasalo H; Nykter M
    Acta Neuropathol Commun; 2023 Nov; 11(1):176. PubMed ID: 37932833
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. IRX1 is a novel gene, overexpressed in high-grade IDH-mutant astrocytomas.
    Sugur HS; Rao S; Sravya P; Athul Menon K; Arivazhagan A; Mehta B; Santosh V
    Pathol Res Pract; 2023 May; 245():154464. PubMed ID: 37116364
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. MGL S3 Chimeric Enzyme Drives Apoptotic Death of EGFR-Dependent Cancer cells through ERK Downregulation.
    Bondarev N; Ivanenko K; Khabusheva E; Lebedev T; Manukhov I; Prassolov V
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361596
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Surgical Management of G3 Gastroenteropancreatic Neuroendocrine Neoplasms: A Systematic Review and Meta-analysis.
    Ziogas IA; Tasoudis PT; Borbon LC; Sherman SK; Breheny PJ; Chandrasekharan C; Dillon JS; Bellizzi AM; Howe JR
    Ann Surg Oncol; 2023 Jan; 30(1):148-160. PubMed ID: 36227392
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Loss of deubiquitylase USP2 triggers development of glioblastoma via TGF-β signaling.
    Tu Y; Xu L; Xu J; Bao Z; Tian W; Ye Y; Sun G; Miao Z; Chao H; You Y; Liu N; Ji J
    Oncogene; 2022 Apr; 41(18):2597-2608. PubMed ID: 35332268
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Expression and prognostic characteristics of m
    Li X; Meng Y
    J Cell Mol Med; 2021 Feb; 25(3):1383-1393. PubMed ID: 33400376
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Cytosine methylation of mature microRNAs inhibits their functions and is associated with poor prognosis in glioblastoma multiforme.
    Cheray M; Etcheverry A; Jacques C; Pacaud R; Bougras-Cartron G; Aubry M; Denoual F; Peterlongo P; Nadaradjane A; Briand J; Akcha F; Heymann D; Vallette FM; Mosser J; Ory B; Cartron PF
    Mol Cancer; 2020 Feb; 19(1):36. PubMed ID: 32098627
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Clinical Utility of Next-Generation Sequencing in Acute Myeloid Leukemia.
    Yang F; Anekpuritanang T; Press RD
    Mol Diagn Ther; 2020 Feb; 24(1):1-13. PubMed ID: 31848884
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. DNMT1 and DNMT3B genetic polymorphisms affect the clinical course and outcome of melanoma patients.
    Maric H; Supic G; Kandolf-Sekulovic L; Maric V; Mijuskovic Z; Radevic T; Rajovic M; Magic Z
    Melanoma Res; 2019 Dec; 29(6):596-602. PubMed ID: 30950914
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Specific Inhibition of dnmt3a/ISGF3γ Interaction Increases the Temozolomide Efficiency to Reduce tumor Growth.
    Cheray M; Pacaud R; Nadaradjane A; Oliver L; Vallette FM; Cartron PF
    Theranostics; 2016; 6(11):1988-1999. PubMed ID: 27698935
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The Importance of Mutational Drivers in GBM.
    Kalkan R
    Crit Rev Eukaryot Gene Expr; 2016; 26(1):19-26. PubMed ID: 27278882
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Integrative functional genomic analysis identifies epigenetically regulated fibromodulin as an essential gene for glioma cell migration.
    Mondal B; Patil V; Shwetha SD; Sravani K; Hegde AS; Arivazhagan A; Santosh V; Kanduri M; Somasundaram K
    Oncogene; 2017 Jan; 36(1):71-83. PubMed ID: 27212030
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Expression of DNA methyltransferases 1 and 3B correlates with EZH2 and this 3-marker epigenetic signature predicts outcome in glioblastomas.
    Purkait S; Sharma V; Kumar A; Pathak P; Mallick S; Jha P; Sharma MC; Suri V; Julka PK; Suri A; Sharma BS; Sarkar C
    Exp Mol Pathol; 2016 Apr; 100(2):312-20. PubMed ID: 26892683
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. MiR-101 reverses the hypomethylation of the LMO3 promoter in glioma cells.
    Liu X; Lei Q; Yu Z; Xu G; Tang H; Wang W; Wang Z; Li G; Wu M
    Oncotarget; 2015 Apr; 6(10):7930-43. PubMed ID: 25829251
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Malignancies of the anal canal: a multi-center retrospective analysis in South China population.
    Sun P; Li YH; Wang W; Chen CQ; Wang LY
    J BUON; 2014; 19(1):103-8. PubMed ID: 24659650
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Intravenous, intralesional and endolymphatic administration of lymphokines in human cancer.
    Pulley MS; Nagendran V; Edwards JM; Dumonde DC
    Lymphokine Res; 1986; 5 Suppl 1():S157-63. PubMed ID: 3784610
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.